Haemolysis after treatment with intravenous immunoglobulin due to anti-A

Transfusion Medicine

Volumn 21, Issue 4, 2011, Pages 267-270

  Morgan, S ^a   Sorensen, P ^a   Vercellotti, G ^b   Zantek, N D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ABO blood group; Haemolysis; Intravenous immunoglobulin

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; ERYTHROCYTE ANTIGEN; HEMOGLOBIN; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RHESUS D ANTIGEN;

ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; CASE REPORT; DIZZINESS; DRUG INDUCED HEADACHE; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; HEMOLYSIS; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; MALE; MYASTHENIA GRAVIS; OSTEOSARCOMA; PLASMAPHERESIS; SQUAMOUS CELL CARCINOMA;

ABO BLOOD-GROUP SYSTEM; ADULT; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; MALE; MIDDLE AGED;

EID: 79960111444     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2011.01078.x     Document Type: Article

References (21)

1. Bertorini, T.E., Nance, A.M., Horner, L.H., Greene, W., Gelfand, M.S. & Jaster, J.H. (1996) Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve, 19, 388-391.
2. Brox, A.G., Cournoyer, D., Sternbach, M. & Spurll, G. (1987) Hemolytic anemia following intravenous gamma globulin administration. The American Journal of Medicine, 82, 633-635.
3. Coghill, J., Comeau, T., Shea, T., Braddy, L., Bandarenko, N., Afenyi-Annan, A. & Harvey, D. (2006) Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG). Biology of Blood and Marrow Transplantation, 12, 786-788.
4. Cohn, E.J., Stron, L.E., Hughes, L.W., Mulford, D.J., Ashworth, J.N., Melin, M. & Taylor, H.L. (1946) Preparation and properties of serum and plasma protein. IV. A system for the separation into fractions of the proteins and lipoprotein components of biological tissue and fluids. Journal of the American Chemical Society, 68, 459-475.
5. Comenzo, R.L., Malachowski, M.E., Meissner, H.C., Fulton, D.R. & Berkman, E.M. (1992) Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. The Journal of Pediatrics, 120, 926-928.
6. Daw, Z., Padmore, R. & Neurath, D. et al. (2008) Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion, 48, 1598-1601.
7. Kitsler, P. & Nitschmann, H. (1962) Large scale production of human plasma fractions: eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler, and Lergier. Vox Sanguinis, 7, 414-424.
8. Malayska, H. & Wieland, D. (1994) The gel test. LabMedicine, 25, 81-85.
9. Nicholls, M.D., Cummins, J.C., Davies, V.J. & Greenwood, J.K. (1989) Haemolysis induced by intravenously-administered immunoglobulin. The Medical Journal of Australia, 150, 404-406.
10. Niosi, P., Lundberg, J., McCullough, J., Park, B.H. & Biggar, D.W. (1971) Blood group antibodies in human immune serum globulin. The New England Journal of Medicine, 285, 1435-1436.
11. Oncley, J.L., Melin, M., Richert, D.A., Cameron, J.W. & Gross, P.M. (1949) The separation of the antibodies, is agglutinins, prothrombin, plasminogen and beta 1-lipoprotein into subfractions of human plasma. Journal of the American Chemical Society, 71, 541-550.
12. Orange, J.S., Hossny, E.M. & Weiler, C.R. et al.(2006) Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Journal of Allergy and Clinical Immunology, 117, S525-S553.
13. Petz, L.D. & Garratty, G. (2004) Immune Hemolytic Anemias (2nd edn), 495-496. Churchill Livingstone, New York.
14. Pierce, L.R. & Jain, N. (2003) Risks associated with the use of intravenous immunoglobulin. Transfusion Medicine Reviews, 17, 241-251.
15. Provan, D., Chapel, H.M., Sewell, W.A.C. & O'Shaughnessy, D. (2008) Prescribing intravenous immunoglobulin: summary of Department of Health guidelines. British Medical Journal, 337, a1831.
16. Roback, J., Combs, M.R., Grossman, B.J. & Hillyer, C. eds (2008) AABB Technical Manual, 878-909. AABB, Bethesda, Maryland.
17. Stangel, M., Hartung, H.P., Marx, P. & Gold, R. (1997) Side effects of high-dose intravenous immunoglobulins. Clinical Neuropharmacology, 20, 385-393.
18. Stangel, M., Kiefer, R., Pette, M., Smolka, M.N., Marx, P. & Gold, R. (2003) Side effects of intravenous immunoglobulins in neurological autoimmune disorders. A prospective study. Journal of Neurology, 250, 818-821.
19. Thomas, M.J., Misbah, S.A., Chapel, H.M., Jones, M., Elrington, G. & Newsom-Davis, J. (1993) Hemolysis after high dose intravenous Ig. Blood, 82, 3789.
20. Wilson, J.R., Bhoopalam, H. & Fisher, M. (1997) Hemolytic anemia associated with intravenous immunoglobulin. Muscle Nerve, 20, 1142-1145.
21. Wittstock, M. & Zettl, U.K. (2006) Adverse effects of treatment with intravenous immunoglobulins for neurological diseases. Journal of Neurology, 253(Suppl. 5), V75-V79.